skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results

Netherlands heart journal, 2008-12, Vol.16 (12), p.436-439

Bohn Stafleu van Loghum 2008 ;ISSN: 1568-5888 ;EISSN: 1876-6250 ;DOI: 10.1007/BF03086194 ;PMID: 19127324

Digital Resources/Online E-Resources

Citations Cited by
  • Title:
    Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results
  • Author: van der Laan, A. M. ; Hirsch, A. ; Nijveldt, R. ; van der Vleuten, P. A. ; van der Giessen, W. J. ; Doevendans, P. A. ; Waltenberger, J. ; ten Berg, J. M. ; Aengevaeren, W. R. M. ; Zwaginga, J. J. ; Biemond, B. J. ; van Rossum, A. C. ; Tijssen, J. G. P. ; Zijlstra, F. ; Piek, J. J.
  • Subjects: Cardiology ; Interuniversity Cardiology Institute of the Netheralnds ; Medical Education ; Medicine ; Medicine & Public Health
  • Is Part Of: Netherlands heart journal, 2008-12, Vol.16 (12), p.436-439
  • Description: During the last decennium, the role of bone marrow mononuclear cells (BMMC) has been underscored in the healing process after acute myocardial infarction (AMI). Although these cells improve left ventricular recovery after AMI in experimental studies, results from large-scale randomised trials investigating BMMC therapy in patients with AMI have shown contradictory results. To address this issue the HEBE study was designed, a multicentre, randomised trial, evaluating the effects of intracoronary infusion of BMMCs and the effects of intracoronary infusion of peripheral blood mononuclear cells after primary percutaneous coronary intervention. The primary endpoint of the HEBE trial is the change in regional myocardial function in dysfunctional segments at four months relative to baseline, based on segmental analysis as measured by magnetic resonance imaging. The results from the HEBE trial will provide detailed information about the effects of intracoronary BMMC therapy on post-infarct left ventricular recovery. In addition, further analysis of the data and material obtained may provide important mechanistic insights into the contribution of BMMCs to natural recovery from AMI as well as the response to cell therapy. This may significantly contribute to the development of improved cell-based therapies, aiming at optimising post-infarct recovery and preventing heart failure. (Neth Heart J 2008;16:436-9.).
  • Publisher: Houten: Bohn Stafleu van Loghum
  • Language: Dutch;English
  • Identifier: ISSN: 1568-5888
    EISSN: 1876-6250
    DOI: 10.1007/BF03086194
    PMID: 19127324
  • Source: Springer Nature OA/Free Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait